Literature DB >> 30615279

Biologika und Immunglobuline für die Therapie des Pyoderma gangraenosum - Analyse von 52 Patienten.

Katharina Herberger1, Joachim Dissemond2, Sarah Brüggestrat1, Christina Sorbe1, Matthias Augustin1.   

Abstract

Entities:  

Year:  2019        PMID： 30615279     DOI： 10.1111/ddg.13741_g

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  2 in total

1.  What's driving dermatology? Contribution title analysis of the largest German Dermatology Congress 2019.

Authors:  Robert Kaczmarczyk; Felix King; Tilo Biedermann; Alexander Zink
Journal:  Digit Health       Date:  2021-04-21

Review 2.  Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Authors:  Sahil Rawal; Sara Kianian; William Guo; Jocellie Marquez; Marissa Ayasse; Katherine A Siamas; Yoojin Lee; Joann Salvemini
Journal:  Arch Dermatol Res       Date:  2021-06-22       Impact factor: 3.017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.